Business Description
0913693 BC Ltd
NAICS : 541710
SIC : 3741
ISIN : CA76027P4006
Description
0913693 BC Ltd is a regenerative medicine company focused on aesthetics and orthopedics. It is a royalty company that holds its primary royalty assets focused on autologous cell therapies that treat functional cellular deficits, including chronic tendon injuries, androgenetic alopecia, and skin aging. The Company is organized into one business unit based on its cell replication technology and has one reportable operating segment. Its product line is RCT-01 Tendon Repair, RCS-01 Skin Rejuvenation, RCH-01 Hair Growth, and DermaPrecise.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 53.69 | |||||
12-1 Month Momentum % | -95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -564.62 | |||||
OCF Margin % | -564.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:REPCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
0913693 BC Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.26 | ||
| EPS (TTM) ($) | - | ||
| Beta | 0.0484 | ||
| 3-Year Sharpe Ratio | -0.85 | ||
| 3-Year Sortino Ratio | -0.96 | ||
| Volatility % | 95 | ||
| 14-Day RSI | 53.69 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -95 | ||
| 52-Week Range ($) | 0.00001 - 0.002 | ||
| Shares Outstanding (Mil) | 73.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
0913693 BC Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
0913693 BC Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2016-08-10 | 0.79 (-4.49%) | ||
| 0.033333:1 Stock Split | 2008-11-28 | 0.30 (-75.00%) | ||
| 6.99301:1 Stock Split | 2004-06-02 | 255.00 (+0.00%) |
Show
Entries
0913693 BC Ltd Frequently Asked Questions
What is 0913693 BC Ltd(REPCF)'s stock price today?
The current price of REPCF is $0.00. The 52 week high of REPCF is $0.00 and 52 week low is $0.00.
When is next earnings date of 0913693 BC Ltd(REPCF)?
The next earnings date of 0913693 BC Ltd(REPCF) is .
Does 0913693 BC Ltd(REPCF) pay dividends? If so, how much?
0913693 BC Ltd(REPCF) does not pay dividend.
Guru Commentaries on OTCPK:REPCF
No articles.
Press Release
Articles on 0913693 BC Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers